Intramural plasminogen activator inhibitor type-1 and coronary atherosclerosis

被引：92

作者：

Sobel, BE ^{[1
]}

Taatjes, DJ ^{[1
]}

Schneider, DJ ^{[1
]}

机构：

[1] Univ Vermont, Coll Med, Burlington, VT USA

来源：

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY | 2003年 / 23卷 / 11期

关键词：

vulnerable plaques; diabetes; fibrinolysis; atherothrombosis; coronary artery disease;

D O I：

10.1161/01.ATV.0000091250.53231.4D

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Altered expression of plasminogen activator inhibitor type- 1 in vessel walls, reviewed here, might affect coronary atherogenesis. Upregulation might exacerbate vasculopathy by potentiating thrombosis and by inhibiting vascular smooth muscle cell migration, resulting in attenuation of thickness of elaborated fibrous caps implicated in the vulnerability of atheroma to rupture.

引用

收藏

页码：1979 / 1989

页数：11

相关论文

共 160 条

[71] Mechanisms of disease: Plasminogen-activator inhibitor type 1 and coronary artery disease. [J].

Kohler, HP ;

Grant, PJ .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (24) :1792-1801

[72] Do PAI-1 and vitronectin promote or inhibit neointima formation?: The exact role of the fibrinolytic system in vascular remodeling remains uncertain [J].

Konstantinides, S ;

Schäfer, K ;

Loskutoff, DJ .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (12) :1943-1945

[73] Non-invasive characterisation of coronary lesion morphology and composition by multislice CT: first results in comparison with intracoronary ultrasound [J].

Kopp, AF ;

Schroeder, S ;

Baumbach, A ;

Kuettner, A ;

Georg, C ;

Ohnesorge, B ;

Heuschmid, M ;

Kuzo, R ;

Claussen, CD .

EUROPEAN RADIOLOGY, 2001, 11 (09) :1607-1611

[74] Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects [J].

Kruszynska, YT ;

Yu, JG ;

Olefsky, JM ;

Sobel, BE .

DIABETES, 2000, 49 (04) :633-639

[75] NIDDM AND ITS METABOLIC CONTROL PREDICT CORONARY HEART-DISEASE IN ELDERLY SUBJECTS [J].

KUUSISTO, J ;

MYKKANEN, L ;

PYORALA, K ;

LAAKSO, M .

DIABETES, 1994, 43 (08) :960-967

[76] Detection of atherosclerosis using a novel positron-sensitive probe and 18-fluorodeoxyglucose (FDG) [J].

Lederman, RJ ;

Raylman, RR ;

Fisher, SJ ;

Kison, PV ;

San, H ;

Nabel, EG ;

Wahl, RL .

NUCLEAR MEDICINE COMMUNICATIONS, 2001, 22 (07) :747-753

[77] ATHEROSCLEROTIC PLAQUE CAPS ARE LOCALLY WEAKENED WHEN MACROPHAGES DENSITY IS INCREASED [J].

LENDON, CL ;

DAVIES, MJ ;

BORN, GVR ;

RICHARDSON, PD .

ATHEROSCLEROSIS, 1991, 87 (01) :87-90

[78] INHIBITION OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 ACTIVITY RESULTS IN PROMOTION OF ENDOGENOUS THROMBOLYSIS AND INHIBITION OF THROMBUS EXTENSION IN MODELS OF EXPERIMENTAL THROMBOSIS [J].

LEVI, M ;

BIEMOND, BJ ;

VANZONNEVELD, AJ ;

TENCATE, JW ;

PANNEKOEK, H .

CIRCULATION, 1992, 85 (01) :305-312

[79]

LEVINE GN, 1995, NEW ENGL J MED, V332, P1354

[80] Genotype-specific transcriptional regulation of PAI-1 expression by hypertriglyceridemic VLDL and Lp(a) in cultured human endothelial cells [J].

Li, XN ;

Grenett, HE ;

Benza, RL ;

Demissie, S ;

Brown, SL ;

Tabengwa, EM ;

Gianturco, SH ;

Bradley, WA ;

Fless, GM ;

Booyse, FM .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (11) :3215-3223

← 3 4 5 6 7 8 9 10 11 12 →